scholarly journals P2.01-46 The Efficacy and Safety of 2nd-Line Nivolumab for Non-Small Cell Lung Cancer in Real-World Practice with Emphasis on Hyperprogession

2019 ◽  
Vol 14 (10) ◽  
pp. S657
Author(s):  
J.C. Lee ◽  
C. Choi ◽  
W. Ji ◽  
S.H. Kim
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung

Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis

2018 ◽  
Vol 19 (3) ◽  
pp. e349-e358 ◽  
Author(s):  
Keigo Kobayashi ◽  
Ichiro Nakachi ◽  
Katsuhiko Naoki ◽  
Ryosuke Satomi ◽  
Morio Nakamura ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Multicenter Analysis

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina

2020 ◽  
Vol 21 (5) ◽  
pp. e380-e387 ◽  
Author(s):  
Claudio Martin ◽  
Lorena Lupinacci ◽  
Florencia Perazzo ◽  
Carlos Bas ◽  
Omar Carranza ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Previously Treated Patients ◽  
Previously Treated

scholarly journals Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study

2020 ◽  
Vol Volume 12 ◽  
pp. 3409-3417 ◽  
Author(s):  
Kun Zhang ◽  
Xiya Ma ◽  
Hongjun Gao ◽  
Hong Wang ◽  
Haifeng Qin ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung

P40.06 A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer

2021 ◽  
Vol 16 (10) ◽  
pp. S1071
Author(s):  
J. Wang ◽  
T. Yi ◽  
Y. Dong ◽  
R. Ran ◽  
F. Cao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung

Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non–small cell lung cancer patients

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Po-Hsin Lee ◽  
Kun-Chieh Chen ◽  
Kuo-Hsuan Hsu ◽  
Yen-Hsiang Huang ◽  
Jeng-Sen Tseng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Alk Positive
Sign in / Sign up

Export Citation Format

Share Document